Kaleidex's Chief Financial Officer speaks about MTI Expo and recent takeovers in exclusive interview.
At the Med-Tech Innovation Expo 2025, the focus was on the latest advancements and innovations in the medical technology sector. Among the highlights was the debut of Kaleidex Group, a company that has recently undergone significant growth through strategic acquisitions.
Jon Lynch, the Chief Financial Officer of Kaleidex Group, discussed the company's presence at the expo and its recent acquisitions. One of the most significant acquisitions was the purchase of OxDevice, a precision engineering and manufacturing company specialising in neurovascular and endovascular devices. This marks Kaleidex’s third acquisition and represents their strategic expansion into these sectors.
Importantly, OxDevice’s leadership and team remain unchanged, with their directors integrating into Kaleidex’s leadership to support growth across the group. This consolidation of capabilities is also evident in the presence of Kirkstall Precision Engineering, another company now part of the Kaleidex Group, which revealed a new visual identity and showcased advanced precision engineering for medical and veterinary fields at the expo.
The Med-Tech Innovation Expo was not just about showcasing new products, but also about fostering discussions and insights. "Insights" magazine featured a preview of the Med-Tech Innovation Conference, an event related to the expo, where industry experts and thought leaders gather to discuss the latest trends and developments in medical technology. Alex Munden, one of the speakers at the conference, discussed the upcoming event in "Insights".
Another exciting development at the expo was Fortec's display of its new rotary encoders. Fortec, a company specialising in the design and manufacture of precision motion control systems, showcased these new encoders at the expo, further demonstrating the innovative spirit of the event.
In summary, the Med-Tech Innovation Expo 2025 was a platform for showcasing the latest advancements in medical technology, fostering discussions, and celebrating the strategic growth of companies like Kaleidex Group. With its recent acquisitions and debut at the expo, Kaleidex Group is poised to make a significant impact in the neurovascular and endovascular device sectors.
The Kaleidex Group's Chief Financial Officer, Jon Lynch, highlights the company's strategic expansion into the neurovascular and endovascular device sectors, following significant growth through several business acquisitions, including OxDevice, a precision engineering and manufacturing company in the technology sector.
At the Med-Tech Innovation Expo, Fortec, a company specializing in technology for precision motion control systems, showcased its new rotary encoders, further demonstrating the expo's focus on innovation and advancements in medical technology.
